Skip to main content
Journal of Patient-Reported Outcomes

Table 3 Interscale Correlations of the EORTC QLQ-C30

From: Assessing the acceptability, reliability, and validity of the EORTC Quality of Life Questionnaire (QLQ-C30) in Kenyan cancer patients: a cross-sectional study

 

PF

RF

CF

EF

SF

FA

NV

PA

DY

SL

AP

CO

DI

FI

RF

0.66

             

CF

0.56

0.53

            

EF

0.43

0.32

0.58

           

SF

0.35

0.42

0.47

0.48

          

FA

−0.63

−0.69

−0.66

−0.55

−0.40

         

NV

− 0.23

− 0.40

− 0.38

− 0.39

− 0.28

0.52

        

PA

−0.60

− 0.64

− 0.53

− 0.41

−0.51

0.73

0.41

       

DY

−0.66

−0.48

−0.52

− 0.39

−0.36

0.51

0.32

0.41

      

SL

−0.68

−0.57

−0.63

− 0.48

−0.46

0.68

0.41

0.67

0.66

     

AP

−0.28

−0.46

−0.31

− 0.33

−0.14

0.61

0.65

0.44

0.24

0.39

    

CO

−0.24

−0.25

−0.38

− 0.40

−0.35

0.46

0.43

0.45

0.27

0.35

0.42

   

DI

−0.19

−0.21

−0.14

− 0.13

−0.11

0.25

0.32

0.17

0.24

0.15

0.19

0.26

  

FI

−0.30

−0.38

−0.25

− 0.27

−0.46

0.39

0.24

0.29

0.15

0.25

0.20

0.07

0.09

 

GL

0.35

0.42

0.20

0.20

0.35

−0.42

−0.29

−0.46

−0.22

− 0.36

−0.21

− 0.22

−0.22

− 0.34

  1. Highest positive and negative correlations are in bold. Negative correlations are due to scoring procedures. PF Physical functioning, RF Role functioning, CF Cognitive functioning, EF Emotional functioning, SF Social functioning, FA Fatigue, NV Nausea and vomiting, PA Pain, DY Dyspnea, SL Sleep disorders, AP Appetite loss, CO Constipation, DI Diarrhea, FI Financial impact, GL Global quality of life, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer QOL measure
Back to article page